These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 11805225

  • 1. Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor.
    Morisset S, Pilon C, Tardivel-Lacombe J, Weinstein D, Rostene W, Betancur C, Sokoloff P, Schwartz JC, Arrang JM.
    J Pharmacol Exp Ther; 2002 Feb; 300(2):621-8. PubMed ID: 11805225
    [Abstract] [Full Text] [Related]

  • 2. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.
    Faucard R, Armand V, Héron A, Cochois V, Schwartz JC, Arrang JM.
    J Neurochem; 2006 Sep; 98(5):1487-96. PubMed ID: 16923161
    [Abstract] [Full Text] [Related]

  • 3. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats.
    Millan MJ, Seguin L, Gobert A, Cussac D, Brocco M.
    Psychopharmacology (Berl); 2004 Jul; 174(3):341-57. PubMed ID: 14985929
    [Abstract] [Full Text] [Related]

  • 4. Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats.
    Mohd-Yusof A, Veliz A, Rudberg KN, Stone MJ, Gonzalez AE, McDougall SA.
    Psychopharmacology (Berl); 2016 Mar; 233(5):893-903. PubMed ID: 26650612
    [Abstract] [Full Text] [Related]

  • 5. The effect of haloperidol on the histaminergic neuron system in the rat brain.
    Ito C, Onodera K, Yamatodani A, Yanai K, Sakurai E, Sato M, Watanabe T.
    Tohoku J Exp Med; 1997 Dec; 183(4):285-92. PubMed ID: 9549828
    [Abstract] [Full Text] [Related]

  • 6. Changes in histamine H3 receptor responsiveness in mouse brain.
    Morisset S, Traiffort E, Arrang JM, Schwartz JC.
    J Neurochem; 2000 Jan; 74(1):339-46. PubMed ID: 10617138
    [Abstract] [Full Text] [Related]

  • 7. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T, Baba S, Ikeda H, Oda Y, Hashimoto K, Shimizu I.
    Eur J Pharmacol; 2018 Jul 05; 830():26-32. PubMed ID: 29684390
    [Abstract] [Full Text] [Related]

  • 8. Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.
    Barik S, de Beaurepaire R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun 05; 29(5):718-26. PubMed ID: 15913875
    [Abstract] [Full Text] [Related]

  • 9. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.
    Gbahou F, Davenas E, Morisset S, Arrang JM.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):945-54. PubMed ID: 20530654
    [Abstract] [Full Text] [Related]

  • 10. Dopaminergic mechanisms underlying the expression of antipsychotic-induced dopamine supersensitivity in rats.
    Servonnet A, Allain F, Gravel-Chouinard A, Hernandez G, Bourdeau Caporuscio C, Legrix M, Lévesque D, Rompré PP, Samaha AN.
    Neuropharmacology; 2021 Oct 01; 197():108747. PubMed ID: 34364897
    [Abstract] [Full Text] [Related]

  • 11. GABA(A) receptors mediate the attenuating effects of a 5-HT(3) receptor antagonist on methamphetamine-induced behavioral sensitization in mice.
    Yoo JH, Lee HK, Kim HC, Lee SY, Jang CG.
    Synapse; 2010 Apr 01; 64(4):274-9. PubMed ID: 19953653
    [Abstract] [Full Text] [Related]

  • 12. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
    Jones CD, Bartee JA, Leite-Browning ML, Blackshear MA.
    Cell Mol Biol (Noisy-le-grand); 2007 May 15; 53(4):15-22. PubMed ID: 17531156
    [Abstract] [Full Text] [Related]

  • 13. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y, Nakamura S, Uda M, Kajii Y, Abe M, Baba A, Matsuda T.
    Neuropharmacology; 2006 Sep 15; 51(4):914-22. PubMed ID: 16863654
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
    Kosten TA, Zhang XY, Kehoe P.
    J Pharmacol Exp Ther; 2005 Aug 15; 314(2):661-7. PubMed ID: 15845857
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW, Bergman J.
    J Pharmacol Exp Ther; 1998 Jun 15; 285(3):1163-74. PubMed ID: 9618419
    [Abstract] [Full Text] [Related]

  • 18. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
    Dhir A, Kulkarni SK.
    Brain Res Bull; 2007 Sep 14; 74(1-3):58-65. PubMed ID: 17683790
    [Abstract] [Full Text] [Related]

  • 19. Sensitized increase of period gene expression in the mouse caudate/putamen caused by repeated injection of methamphetamine.
    Nikaido T, Akiyama M, Moriya T, Shibata S.
    Mol Pharmacol; 2001 Apr 14; 59(4):894-900. PubMed ID: 11259635
    [Abstract] [Full Text] [Related]

  • 20. Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.
    López-Arnau R, Martínez-Clemente J, Pubill D, Escubedo E, Camarasa J.
    Br J Pharmacol; 2012 Sep 14; 167(2):407-20. PubMed ID: 22509960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.